Open AccessHemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
Author(s) -
Miguel A. Escobar,
Cindy Leissinger,
Guy Young
Publication year - 2022
Publication title -
journal of the advanced practitioner in oncology
Language(s) - English
Resource type - Journals
eISSN - 2150-0886
pISSN - 2150-0878
DOI - 10.6004/jadpro.2022.13.4.8
Subject(s) - medicine , quality of life (healthcare) , intensive care medicine , pediatrics , nursing
Hemophilia A is a rare inherited bleeding disorder characterized by a deficiency in factor VIII. The evolution of currently approved prophylaxis therapy in hemophilia A will be reviewed, including the clinical value of prophylaxis, real-world experience with prophylaxis, and patient quality-of-life factors that must be considered when choosing treatment options for these patients.